CSBR Champions Oncology Inc.

Champions Oncology Inc is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs.

$11.46
As of 04/13/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  13,390,172
Average volume:  42,555
Market cap:   $151,978,452
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    15870P307
ISIN:        US15870P3073
Sedol:      BYS3HH4
Valuation   (See tab for details)
PE ratio:   -123.46
PB ratio:   19.30
PS ratio:   3.87
Return on equity:   -15.65%
Net income %:   -3.14%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy